Geriatric screening in the treatment of elderly patients with ovarian carcinoma
- Conditions
- English: ovarian carcinoma, ovarian cancerDutch: ovariumcarcinoom, eierstokkanker
- Registration Number
- NL-OMON28593
- Lead Sponsor
- The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 320
Inclusion Criteria
A woman diagnosed with primary ovarian/fallopian/peritoneal carcinoma FIGO stage II, III or IV OR
- A woman with a high suspicion of primary ovarian/fallopian/peritoneal carcinoma FIGO stage II, III or IV (a high suspicion of advanced stage ovarian/fallopian/peritoneal carcinoma should be based on imaging suggesting evidence of metastasized disease (i.e. signs of pelvic, abdominal or extra-abdominal metastases))
- Aged 70 years or older
- Able to complete a Dutch questionnaire
- Written and signed informed consent
Exclusion Criteria
- Not being able to read or write Dutch, as they are not able to complete a Dutch questionnaire
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoints include the percentage of started and completed therapies (standard as well as adapted) in 'geriatric screening care' and 'care as usual' and the difference in percentage in completed treatment in both groups.
- Secondary Outcome Measures
Name Time Method Secondary endpoints include health related quality of life; toxicity of treatment; progression free- and overall survival and cost-effectiveness in terms of incremental costs per quality adjusted life year from a societal perspective.